COPAY
ASSISTANCE
PROGRAM *

link

Is NeutraSal

RIGHT FOR
MY PATIENTS?

link

What is

NeutraSal?

link

HELPFUL

RESOURCES

link

INDICATIONS

NeutraSal® is indicated for dryness of the mouth (hyposalivation, xerostomia) and dryness of the oral mucosa due to drugs that suppress salivary secretion. Not intended to prevent xerostomia or oral mucositis.

IMPORTANT SAFETY INFORMATION

  • Patients should avoid eating or drinking for at least 15 minutes after use
  • Solution should not be swallowed but be spit out.
  • Not intended for systemic use to treat any diseases of the throat or upper gastrointestinal tract
  • Not intended for use as an antacid
  • No adverse events anticipated if swallowed accidentally
  • Contains sodium; consult with patients on a low sodium diet
  • No known interactions with medicinal or other products

Please click here for Instructions for Use.

1. NeutraSal [Instructions for Use]. Invado Pharmaceuticals, LLC. 2. Levin EZ. Management of xerostomia and microflora with supersaturated calcium-phosphate rinse. 2013. www.neutrasal.com. Accessed June 8, 2015. 3. Levin EZ. The beneficial effects of a supersaturated calcium phosphate rinse on the oral cavity in xerostomia patients. Tulsa, OK: PennWell Publications; 2014. 4. Dass K, Armstrong J, Godwin J, et al. Efficacy of NeutraSal (Supersaturated Calcium Phosphate Rinse) in the Prevention and Treatment of Chemotherapy-induced or Radiotherapy-induced Oral Mucositis. ASTRO 2012 Study Registry Abstract; presented May 2012.